CATALOGO DEI PRODOTTI DELLA RICERCA

COLIZZI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.602
EU - Europa 2.529
AS - Asia 2.312
SA - Sud America 382
AF - Africa 48
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 6
Totale 7.893
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.531
RU - Federazione Russa 1.089
SG - Singapore 829
CN - Cina 694
IT - Italia 494
BR - Brasile 284
VN - Vietnam 258
FR - Francia 202
GB - Regno Unito 200
HK - Hong Kong 197
IE - Irlanda 164
SE - Svezia 148
DE - Germania 93
KR - Corea 73
BD - Bangladesh 63
AR - Argentina 36
CA - Canada 32
ID - Indonesia 32
IN - India 32
FI - Finlandia 29
JP - Giappone 29
MX - Messico 24
EC - Ecuador 23
TR - Turchia 21
UA - Ucraina 21
ZA - Sudafrica 19
NL - Olanda 18
PK - Pakistan 14
AU - Australia 13
ES - Italia 13
PL - Polonia 13
CO - Colombia 11
IQ - Iraq 10
SA - Arabia Saudita 10
MA - Marocco 7
PH - Filippine 7
PY - Paraguay 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
IL - Israele 6
MY - Malesia 6
UZ - Uzbekistan 6
CH - Svizzera 5
AT - Austria 4
ET - Etiopia 4
KE - Kenya 4
BE - Belgio 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
JM - Giamaica 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
RO - Romania 3
UY - Uruguay 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
EU - Europa 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
JO - Giordania 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
MD - Moldavia 2
PT - Portogallo 2
QA - Qatar 2
SD - Sudan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BW - Botswana 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
LY - Libia 1
MT - Malta 1
NG - Nigeria 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 7.887
Salva come PNG Salva come JPEG
Città #
Ashburn 409
Singapore 398
San Jose 302
Chandler 297
Moscow 296
Hong Kong 194
Dallas 180
Dublin 159
Southend 142
Beijing 135
Council Bluffs 126
Verona 111
The Dalles 89
Ho Chi Minh City 86
Lawrence 73
Princeton 73
Wilmington 67
New York 58
Jacksonville 53
Hanoi 45
Los Angeles 43
Nanjing 43
Redondo Beach 33
Santa Clara 33
Milan 29
Buffalo 28
Dong Ket 28
Sindelfingen 26
Jinan 25
Shenyang 25
São Paulo 25
Hebei 24
Tokyo 24
Rome 23
Tianjin 23
Jakarta 21
Guangzhou 20
Denver 17
Lappeenranta 17
Changsha 16
Chicago 16
Guangdong 16
Ningbo 16
San Francisco 16
Bolzano 15
Nanchang 14
Columbus 13
Haikou 13
Montreal 13
Nuremberg 13
Redwood City 13
Zhengzhou 13
Bologna 12
Johannesburg 12
Redmond 12
Seattle 12
Brooklyn 11
Da Nang 11
Hangzhou 11
Houston 11
Amsterdam 10
Helsinki 10
Kent 10
Norwalk 10
Warsaw 10
Ann Arbor 9
London 9
Mexico City 9
Phoenix 9
Poplar 9
Quito 9
Toronto 9
Atlanta 8
Charlotte 8
Curitiba 8
Lanzhou 8
Orem 8
Stockholm 8
Taizhou 8
Adrano 7
Ancona 7
Ankara 7
Brasília 7
Frankfurt am Main 7
Mumbai 7
Rio de Janeiro 7
Shanghai 7
Taiyuan 7
Washington 7
Boardman 6
Boston 6
Dearborn 6
Fairfield 6
Falls Church 6
Haiphong 6
Melbourne 6
Rio De Janeiro 6
Riyadh 6
Tashkent 6
Baghdad 5
Totale 4.383
Salva come PNG Salva come JPEG
Nome #
Lo stigma nella salute mentale 236
Postural control in childhood: investigating the neurodevelopmental gradient hypothesis 196
Adolescent lifestyle behaviors, coping strategies and subjective wellbeing during the COVID-19 pandemic: an online student survey 184
Effectiveness of equine-assisted activities and therapies for improving adaptive behavior and motor function in autism spectrum disorder 177
Psychosocial and behavioral impact of COVID-19 in autism spectrum disorder: an online parent survey 161
Investigating gait, movement, and coordination in children with neurodevelopmental disorders: is there a role for motor abnormalities in atypical neurodevelopment? 148
Do cannabis users develop tolerance for the psychoactive effects of delta-9-tetrahydrocannabinol? An fMRI study 146
O3.4. DOES CANNABIS INDUCE PSYCHOSIS BY ALTERING GLUTAMATE SIGNALING IN THE STRIATUM? 145
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 141
Cannabis use and the development of tolerance: a systematic review of human evidence 141
COGNITIVE DEFICITS AS INTERMEDIATE PHENOTYPE IN SCHIZOPHRENIA 140
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis 139
Descriptive psychopathology of the acute effects of intravenous Delta-9-Tetrahydrocannabinol administration in humans 137
Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis 136
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids 134
Cannabis users are less sensitive to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol administration 132
Attachment styles in transsexual patients and clinical and nonclinical control groups: a response 130
Cannabis and cognition: connecting the dots towards the understanding of the relationship 129
Medically unexplained symptoms in the times of Covid-19 pandemic: a case-report 129
Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains 128
Additional evidence for neuropsychiatric manifestations in Mosaic Trisomy 20: a case report and brief review 128
Cannabis: neuropsychiatry and its effects on brain and behavior 126
Differential sensitivity to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol associated with its differential acute effects on glial function and cortisol 124
Differential gene expression analysis in blood of first episode psychosis patients 122
The effectiveness of lurasidone add-on for residual aggressive behavior and obsessive symptoms in antipsychotic-treated children and adolescents with Tourette syndrome: preliminary evidence from a case series 122
Sociodemographic and clinical changes in pediatric in-patient admissions for mental health emergencies during the COVID-19 pandemic: March 2020 to June 2021 122
Palmitoylethanolamide and its biobehavioral correlates in autism spectrum disorder: a systematic review of human and animal evidence 121
Dissociative symptoms in individuals with gender dysphoria: is the elevated prevalence real? 120
Gender-oriented mental health prevention: a reappraisal 119
Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: a 2 year follow-up study 118
Poster #103 INTERACTION BETWEEN COMT GENOTYPE, CANNABIS USE, AND BFQ MEASURES OF SOCIABILITY 113
Cannabis and psychosis: what do we know and what should we do? 113
Stigma as the main obstacle in health care and human rights among people with mental disorders. A rights-based ethics approach 107
Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A) 107
Poster #M195 THE INTERACTION BETWEEN CNR1 GENETIC VARIATION AND CANNABIS EXPOSURE PREDICTS PREFRONTAL FUNCTIONAL CONNECTIVITY AND BEHAVIOR DURING WORKING MEMORY 105
F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY 103
The 2019 Schizophrenia International Research Society Conference, 10-14 April, Orlando, Florida: A summary of topics and trends 101
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study 99
Is the adolescent brain at greater vulnerability to the effects of cannabis? A narrative review of the evidence 99
Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria 99
Poster #35 STUDYING EPISODIC MEMORY CEREBRAL NETWORK: A NOVEL EVENT-RELATED TASK FOR FMRI 98
Does cannabis composition matter? Differential effects of delta-9-tetrahydrocannabinol and cannabidiol on human cognition 98
S224. DELTA-9-TETRAHYDROCANNABINOL CHALLENGE IN CANNABIS USERS AND NON-USERS DIFFERENTIALLY AFFECTS BRAIN FUNCTION AND BEHAVIOR: AN FMRI STUDY OF DEVELOPMENT OF TOLERANCE 96
Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing 95
To treat or not to treat: puberty suppression in childhood-onset gender dysphoria 94
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis 93
Should we be concerned about stigma and discrimination in people at risk for psychosis? A systematic review 91
Prevention and early intervention in youth mental health: is it time for a multidisciplinary and trans-diagnostic model for care? 91
The effect of cross-sex hormonal treatment on gender dysphoria individuals' mental health: a systematic review 88
Transsexual patients' psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study 88
Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis 85
Interaction between functional genetic variation of DRD2 and cannabis use on risk of psychosis 82
Hormonal treatment reduces psychobiological distress in gender identity disorder, independently of the attachment style 82
Neurocognitive effects of cannabis: Lessons learned from human experimental studies 82
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition 82
Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use 80
The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic 79
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study 78
Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case-control study 77
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence 77
Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosis 76
Is there sufficient evidence that cannabis use is a risk factor for psychosis? 76
The relationship between dissociative experiences and cannabis use: a systematic review 75
Functional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior 73
The neural substrate of reward anticipation in health: a meta-analysis of fMRI findings in the monetary incentive delay task 71
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 71
Occupational Stress Among Italian Postgraduate Medical Trainees: A Pilot Study for the Validation of the SCOPE Questionnaire 70
S152. CANNABIDIOL INDUCED MODULATION OF MEDIOTEMPORAL ACTIVITY DURING A VERBAL MEMORY TASK IN FIRST-EPISODE PSYCHOSIS 70
Hyperprolactinaemia in first episode psychosis: a longitudinal assessment 70
Epigenetic mediation of AKT1 rs1130233's Effect on delta-9-tetrahydrocannabinol-induced medial temporal function during fear processing 70
Substance use, medication adherence and outcome one year following a first episode of psychosis 67
Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure 66
Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort 64
Editorial: The endocannabinoid system: filling the translational gap between neuroscience and psychiatry 61
Totale 7.993
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.087
article - articoli 29.904
book - libri 0
conference - conferenze 450
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 733
Totale 62.174
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202166 0 0 0 0 0 0 0 0 0 0 0 66
2021/2022443 37 52 9 33 28 13 7 45 19 15 18 167
2022/2023930 87 81 103 129 115 211 5 53 107 10 21 8
2023/2024552 22 39 69 45 41 91 35 68 8 23 83 28
2024/20251.216 67 84 48 221 46 45 64 59 188 53 93 248
2025/20264.019 273 186 277 725 882 188 373 257 286 260 140 172
Totale 7.993